Airway Management Devices Market Size, Statistics, Growth Trend Analysis, and Forecast Report, 2022 – 2032

Airway Management Devices Market is segmented by Product Type (Supraglottic Device, Intragalactic Device, Resuscitators, Laryngoscope); Patient Age (Adult, Pediatric); End-user (Operating Room (OR), Intensive Care Unit (ICU), Others); By Geography (North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Nordic Region, Rest of Europe), Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa (South Africa, Rest of the Middle East & Africa)

  • Report ID : MD2932
  • |
  • Pages : 220
  • |
  • Tables : 75
  • |
  • Formats :

The Airway Management Devices Market was valued at US $1.18 billion in 2022 and is projected to reach US $2.51 billion by 2032, growing at a CAGR of 7.81% during the forecast period.
Positive air pressure devices like ventilators are frequently needed for patients with severe respiratory illnesses or low oxygen saturation. The tools used for airway management include endotracheal tubes for airway management, laryngoscope handles and blades, positive airway pressure devices, and different-sized oropharyngeal airways. During operations, these gadgets are mostly employed in operating rooms. Leading competitors in the global airway management devices market are also concentrating on creating technologically improved respiratory equipment in order to improve patient outcomes.

Increase in the Respiratory Diseases Worldwide: Key Driver
The demand for airway management devices is being driven by an increase in the prevalence of chronic respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD). Airways and lung structures are extensively impacted by chronic obstructive pulmonary disorders, bronchitis, emphysema, lung cancer, and other respiratory tract neoplasms. Due to environmental and lifestyle-related variables such air pollution, smoking, sedentary behavior, and stress, the incidence of respiratory disorders is rising. The need for airway management devices is driven by the increase of patients with these diseases as well as the quick development and availability of portable, affordable, and simple-to-use airway equipment for the treatment of these ailments. Unique therapeutic methods that include airway management tools include airway stenting and the airway clearing system. The World Health Organization (WHO) estimates that the third-leading cause of mortality worldwide in 2019 was chronic obstructive pulmonary disease (COPD), which affected over 65 million people and claimed 3 million lives. More than 80% of these fatalities took place in low- and middle-income nations (LMIC). Most patients with viral, chronic, and cardiac conditions have difficulties with dieted treatment. Similar to this, those who are critically ill or have been in a vehicle accident need to be cleared right away to ensure their safety. As the number of such cases rises, there is an increasing demand for airway devices. The need for ventilation is becoming more and more important due to an oxygen deficit and respiratory failure.

The Geriatric Populations High Susceptibility to Chronic Respiratory Diseases will drive Demand for Airway Management Devices.
The rise in world population can be ascribed to an increase in peoples life expectancy over the last decade. A persons immune system diminishes with age. As a result, the growth in the older population raises the risk of developing numerous diseases. The number of adults above the age of 60 is likely to increase in the future years. The rapidly growing senior population has increased the occurrence and prevalence of chronic respiratory disorders. This is expected to increase demand for airway management devices throughout the projected period. Furthermore, as the prevalence of chronic respiratory disorders (CRD) in adults rises, so does the demand for airway management devices. According to Centers for Disease Control and Prevention (CDC) data, the prevalence of COPD, emphysema, or chronic bronchitis in adults rose in 2020. As a result, the growing number of individuals suffering from emphysema or chronic bronchitis has raised global demand for airway management devices.

Lack of Reimbursements in Developing Countries Restraints the Market Growth
Due to their ineffective healthcare insurance programmes or absence thereof, developing nations have poor adoption rates for pricey airway management devices. For instance, the World Bank Group estimates that the average cost of healthcare in poor nations is roughly USD 80 per person year (or USD 0.5 trillion). Due to the lack of support for universal health care, such out-of-pocket expenses have had a significant negative influence on the poors financial situation across developing nations. These nations are now more susceptible to the danger of COVID-19 and chronic illnesses as a result of these situations. The gap in funding needed to provide the population with universal health care is anticipated to reach USD 176 billion by 2030, according to research by the World Bank titled "High-Performance Health Financing for Universal Health Coverage" (across 54 of the poorest nations). The poor adoption of expensive medical equipment like video laryngoscopes and sophisticated surgical techniques in underdeveloped nations is a major limitation on the market for airway management devices because of the high out-of-pocket expenditures of healthcare. As the number of airway management devices rises, complications and restrictions associated with airway control due to intubation and other variables are to be expected. Endotracheal intubation is the most widely used device, although it comes with dangers and consequences. Because of inadequate reimbursement mechanisms or a lack of public insurance coverage for healthcare, most poor nations have low adoption rates for pricey airway management devices.

Rise in Demand of Single-use Airway Management Devices Creates Opportunity in the Market
Single-use medical devices are used in a wide range of applications in the healthcare business, including airway control. Single-use equipment such as endotracheal tubes, tracheostomy tubes, laryngoscope blades, and resuscitators are widely used in healthcare institutions that provide value-based care and treat critically ill patients with highly contagious illnesses such as H1N1 influenza or severe pneumonia. Furthermore, single-use devices have various advantages over reusable devices, including the fact that they are pre-sterilized and may be utilized immediately, assuring patient safety against healthcare-associated illnesses (HAI). Another important consideration is the time saved on cleaning and disinfecting. Disposable gadgets do not require cleaning or decontamination because they are pre-sterilized and discarded after use. The time saved can be used for other important tasks. Because of these advantages, producers are increasingly emphasizing single-use airway management devices. Furthermore, the COVID-19 pandemic has increased the usage of single-use airway management devices throughout healthcare institutions as they strive to fulfil infection-control criteria. COVID-19 patients who require ventilation are frequently intubated with single-use endotracheal tubes or tracheostomy tubes.

North America holds the dominant position in the growing demand for Airway Management Devices Market
North America held the greatest percent of the international airway management devices market in 2021, and this trend is expected to continue over the forecast period as improved healthcare systems evolve. The regions market share is being boosted by a growth in the regions senior population, as well as the accessibility of technologically improved airway equipment. The higher incidence of respiratory illnesses such as COPD, asthma, pneumonia, and cystic fibrosis is driving up demand for airway management devices in the United States. Furthermore, the presence of significant market competitors in the area, as well as new product launches, approvals, mergers and acquisitions, and collaborations, is projected to boost the airway management devices market. Due to favourable reimbursement policies and an increase in healthcare R&D investment, as well as the growing incidence of chronic illnesses such as COPD, the U.S. market will enjoy significant growth during the projected period.

Top Companies and Recent Strategic Developments in the Airway Management Devices Market
• In October 2020, Olympus Corporation announced the commercial introduction of HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS) developed by M.I. Tech and supplied exclusively by Olympus in the United States.
• In September 2020, VBM Medizintechnik GmbH (Germany) announced that the ScalpelCric kit has received 510(k) approval from the US FDA. According to the Difficult Airway Society (DAS) 2015 standards, the kit is intended for use in performing cricothyrotomy operations with the scalpel approach.
• In May 2022, Medtronic plc, a global leader in health technologies, announced the completion of its acquisition of Intersect ENT, expanding the companys thorough ear, nose, and throat (ENT) portfolio with advanced designs used in sinus processes to improve post-operative consequences and treat nasal polyps.
• In May 2021, Medtronic plc introduced the first-of-its-kind SonarMed airway measuring system for paediatric patients in the United States. The gadget detects ETT (endotracheal tube) blockages and verifies locations in real time using acoustic technology.

Years considered for this report
• Historical Years: 2019-2022
• Base Year: 2021
• Forecast Period: 2022-2032

Airway Management Devices Market Research Report Analysis Highlights
• Historical data available (as per request)
• Estimation/ projections/ forecast for revenue and unit sales (2022 - 2032)
• Data breakdown for application Industries (2022 - 2032)
• Integration and collaboration analysis of companies
• Capacity analysis with application sector breakdown
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategies adopted by emerging companies

Airway Management Devices Market Segmentation and Revenue Breakdown
By Product Type (Revenue, USD Million, 2022 -2032)
• Supraglottic Device
• Intragalactic Device
• Resuscitators
• Laryngoscope

By Patient Age (Revenue, USD Million, 2022 -2032)
• Adult
• Pediatric

By End-use Outlook (Revenue, USD Million, 2022 -2032)
• Operating Room (OR)
• Intensive care Unit (ICU)
• Others

By Geography Outlook (Revenue, USD Million, 2022 -2032)
• North America (U.S., Canada)
• Europe (Germany, France, U.K., Italy, Spain, Nordic Region, Rest of Europe)
• Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (South Africa, Rest of the Middle East & Africa)

Key Companies
• Teleflex Incorporated
• GE Healthcare
• Medtronic plc
• Koninklijke Philips N.V.
• Smiths Medical
• Ambu A/S
• Olympus Corporation
• Karl Storz GmbH & Co. KG
• Medline Industries, Inc.


Available Versions of Global Airway Management Devices Market Report:

The United States Airway Management Devices Market Report
Europe Airway Management Devices Market Report
Asia Pacific Airway Management Devices Market Report
India Airway Management Devices Market Report

• Customization can be done in the existing research scope to cater to your specific requirements without any extra charges* (terms and conditions apply).
• Send us a query to get the Table of Contents and Research Scope along with the research proposal.

Fill out the sample request form OR reach out directly to David Correa at his email: -


20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail